These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27733236)

  • 21. The Cloacal Microbiome of Five Wild Duck Species Varies by Species and Influenza A Virus Infection Status.
    Hird SM; Ganz H; Eisen JA; Boyce WM
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic.
    Leknes H; Sturtzel IE; Dye C
    Sci Total Environ; 2012 Jan; 414():632-8. PubMed ID: 22127154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction, risk and control of anti-influenza drugs in the Yodo River Basin, Japan during seasonal and pandemic influenza using the transmission model for infectious disease.
    Azuma T; Nakada N; Yamashita N; Tanaka H
    Sci Total Environ; 2015 Jul; 521-522():68-74. PubMed ID: 25828414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
    Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
    Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.
    Song MS; Marathe BM; Kumar G; Wong SS; Rubrum A; Zanin M; Choi YK; Webster RG; Govorkova EA; Webby RJ
    J Virol; 2015 Nov; 89(21):10891-900. PubMed ID: 26292325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of Intercontinental Spread and Uncommon Variants of Low-Pathogenicity Avian Influenza Viruses in Ducks Overwintering in Guatemala.
    Gonzalez-Reiche AS; Nelson MI; Angel M; Müller ML; Ortiz L; Dutta J; van Bakel H; Cordon-Rosales C; Perez DR
    mSphere; 2017; 2(2):. PubMed ID: 28405632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
    Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
    Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
    Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterization of low pathogenic H5N1 and co-circulating avian influenza viruses in wild mallards (Anas platyrhynchos) in Belgium, 2008.
    Van Borm S; Vangeluwe D; Steensels M; Poncin O; van den Berg T; Lambrecht B
    Avian Pathol; 2011 Dec; 40(6):613-28. PubMed ID: 22107096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
    J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Influenza A Viruses in Ducks Sampled in Northwestern Minnesota and Evidence for Predominance of H3N8 and H4N6 Subtypes in Mallards, 2007-2016.
    Hollander LP; Fojtik A; Kienzle-Dean C; Davis-Fields N; Poulson RL; Davis B; Mowry C; Stallknecht DE
    Avian Dis; 2019 Mar; 63(sp1):126-130. PubMed ID: 31131568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does influenza A virus infection affect movement behaviour during stopover in its wild reservoir host?
    Bengtsson D; Safi K; Avril A; Fiedler W; Wikelski M; Gunnarsson G; Elmberg J; Tolf C; Olsen B; Waldenström J
    R Soc Open Sci; 2016 Feb; 3(2):150633. PubMed ID: 26998334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerosol Transmission of Gull-Origin Iceland Subtype H10N7 Influenza A Virus in Ferrets.
    Guan M; Hall JS; Zhang X; Dusek RJ; Olivier AK; Liu L; Li L; Krauss S; Danner A; Li T; Rutvisuttinunt W; Lin X; Hallgrimsson GT; Ragnarsdottir SB; Vignisson SR; TeSlaa J; Nashold SW; Jarman R; Wan XF
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
    Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
    Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of embryonated chicken egg as a model to study the susceptibility of avian influenza H9N2 viruses to oseltamivir carboxylate.
    Tare DS; Pawar SD
    J Virol Methods; 2015 Nov; 224():67-72. PubMed ID: 26297959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L; Li Y; Zhang L; Hou T
    J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.